AGEN
NASDAQ · Biotechnology
Agenus Inc
$9.43
+0.89 (+10.42%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+304.3% upside
Low Target
$23.34
Average Target
$38.13
High Target
$40.06
Current Price
$9.43
Current
$9.43
$9.43
Target
$38.13
$38.13
$23.34
$38.13 avg
$40.06
Scenario Analysis
Bear Case
$23.34
147.5%
Low target
Base Case
$38.13
+304.3%
Avg target
Bull Case
$40.06
+324.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$8.85
6.6% from high
52-Week Low
$2.71
+248.0% from low
Target vs 52W High
$38.13
+330.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |